Depot medroxy progesterone acetate: a poor preparatory agent for endometrial resection

Area of Science:

• Gynecology
• Reproductive Medicine
• Surgical Endoscopy

Background:

• Excessive uterine bleeding is a common gynecological issue.
• Endometrial resection is a surgical option for managing heavy menstrual bleeding.
• Hormonal pre-medication is sometimes used to prepare the endometrium for resection.

Purpose of the Study:

• To assess the effectiveness of depot medroxy progesterone acetate (DMPA) as a pre-operative medication for endometrial resection.
• To compare outcomes of endometrial resection with and without DMPA pre-medication.

Main Methods:

• A randomized controlled trial involving 50 women undergoing endometrial resection for excessive uterine bleeding.
• Patients were divided into two groups: one receiving DMPA and a control group receiving no hormonal pre-medication.
• Histopathological analysis of resected tissue and follow-up for up to 4 years were conducted.

Main Results:

• DMPA administration resulted in a thicker, more edematous endometrium, leading to increased fluid consumption during surgery.
• No statistically significant difference in achieving amenorrhea or spotting was observed between the DMPA and control groups (44% vs. 64%).
• A small number of patients in both groups required repeat procedures or hysterectomy due to unsatisfactory outcomes.

Conclusions:

• Depot medroxy progesterone acetate (DMPA) does not appear to offer additional benefits as a preparatory agent for endometrial resection.
• Larger-scale studies are necessary to identify any subtle differences in outcomes between pre-treated and non-pre-treated patients.